GlassScriptPhysician profile
Dipak Ramkumar
NPI 1639412976
$147,579.47
in general payments reported to CMS, 2019-2025
23 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $47.75 · 2021: $396 · 2022: $3,613 · 2023: $14K · 2024: $50K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95K · Travel and Lodging: $30K · Food and Beverage: $12K · Consulting Fee: $4,988 · Gift: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95,145.00 |
| Travel and Lodging | $29,702.48 |
| Food and Beverage | $12,391.78 |
| Consulting Fee | $4,988.00 |
| Gift | $211.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $106,466.46 | 2024-2025 | Ogsiveo |
| Medtronic, INC. | $17,952.90 | 2022-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Uoc USA INC | $8,573.26 | 2022-2025 | Ustar II, U-Star, Conformity, U2, U2 Press-Fit and Psi |
| Stryker Corporation | $5,852.21 | 2019-2025 | Mako, Pro, Optablate |
| Smith+Nephew, INC. | $1,962.76 | 2021-2025 | Smart Tsf, Spatial Frame, Evos |
| Innovation Technologies INC | $1,786.95 | 2022-2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $1,490.73 | 2024 | Oss Orthopedic Salvage System |
| Onkos Surgical, INC. | $730.63 | 2021-2024 | Eleos Limb Salvage System |
| Deciphera Pharmaceuticals INC. | $373.54 | 2025 | Romvimza, Qinlock |
| Cerapedics INC. | $366.40 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Dilon Technologies, INC. | $364.91 | 2024 | Hemoblast Bellows |
| Illuminoss Medical, INC. | $221.40 | 2021-2025 | |
| Galvanize Therapeutics, INC | $194.06 | 2023-2024 | Aliya System |
| Bonalive INC | $180.98 | 2024 | |
| Osteocentric Technologies, INC. | $176.30 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $165.00 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $140.20 | 2024 | Prevena, Prevena Restor Arthroform, V.A.C. Veraflo |
| Depuy Synthes Sales INC. | $129.28 | 2025 | Motoband, Actis, Inhance |
| Bone Support INC. | $122.46 | 2022-2025 | Cerament G, Ceramentbone Void Filler |
| Emd Serono, INC. | $110.25 | 2025 | |
| Tempus Ai, INC | $93.23 | 2024 | Xt Cdx |
| Convatec INC. | $92.23 | 2023 | |
| Kerecis Limited | $33.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipak Ramkumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.